A Phase II, double-blind, placebo-controlled, dose finding study to evaluate the safety and efficacy of Ipamorelin compared to placebo for the recovery of gastrointestinal function in patients following small or large bowel resection with primary anastomosis.

A multicenter, prospective, observational study to assess the 30 day and 360 day major adverse event (death, stroke, or MI) rate of stenting with cerebral emboli protection in the treatment of atherosclerotic obstructive carotid artery disease in high-surgical risk patients.